ClinicalTrials.gov This study is currently recruiting participants. Verified by Sanofi Pasteur MSD, February 2011 First Received: February 24, 2011 No Changes Posted Purpose Primary objective: • To demonstrate that administration of V503 induces non-inferior Geometric Mean Titers (GMTs) (for serum anti-HPV16 and anti-HPV18) compared to GARDASIL. Secondary objectives: To evaluate the tolerability of V503 […]
National Plan Gives Shot in the Arm to Immunization Efforts
Medscape Medical News Neil Osterweil February 18, 2011 (Washington, DC) — The US Department of Health and Human Services has taken the wraps off its 2010 National Vaccine Plan, aimed at improving access to currently available vaccines and spurring development of new ones. The plan’s launch, announced here at a meeting of the National Vaccine […]
Protecting One More Girl
Planned documentary explores the dangers of HPV vaccine Honolulu Weekly by Margot Seeto | Mar 2, 2011 “People don’t just fall over dead.” The One More Girl project / Why would two young men make a documentary about women’s health? For brothers Ryan and David Richardson, who live in Honolulu, the personal became the political. […]
HPV Affects Half Of U.S. Men
The Huffington Post Dr. Jon LaPook Medical correspondent for the CBS Evening News with Katie Couric Posted: March 1, 2011 07:02 AM A study out yesterday in The Lancet by Moffitt Cancer Center researcher Anna Giuliano, Ph.D., and her colleagues finds that 50 percent of men ages 18 to 70 in Brazil, Mexico, and the […]
Cervical Cancer vs Prostate Cancer: Is the FDA practicing sexual discrimination?
FDA advisory panels reject the use of two separate prostate cancer prevention measures yet approve cervical cancer preventive shots using virtually the same criteria. What is wrong with this picture? FOR IMMEDIATE RELEASE PRLog (Press Release) – Mar 01, 2011 – November 2010, an FDA advisory panel soundly rejected the proposed use of two drugs, […]
- « Previous Page
- 1
- …
- 36
- 37
- 38
- 39
- 40
- …
- 141
- Next Page »